Tim Cockayne is an experienced oncology business professional currently serving as an Oncology Business Director at Incyte since July 2020, after working as an Oncology Therapeutic Specialist. Prior to Incyte, Tim Cockayne was a Senior Oncology Specialist focused on Hematology/Multiple Myeloma at Amgen from June 2018 to July 2020, where expertise in Kyprolis was developed. Tim Cockayne's career includes notable roles at Merck, including Immunotherapy Oncology Specialist responsible for launching Keytruda and implementing PD-1 testing, as well as Executive Specialty Representative. Early career experiences as District Sales Manager and HQ Data Analyst and Systems Manager contributed to a diverse skill set. Educational qualifications include an MBA from the University of Vermont and a Bachelor's degree in Sports Medicine from the University of Rhode Island.
This person is not in any teams
This person is not in any offices